Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Intec Pharma Ltd (NTEC)

    Price:

    9.63 USD

    ( - -1.37 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    NTEC
    Name
    Intec Pharma Ltd
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    9.630
    Market Cap
    0
    Enterprise value
    -102.600k
    Currency
    USD
    Ceo
    Jeffrey Meckler
    Full Time Employees
    36
    Ipo Date
    2015-07-30
    City
    Jerusalem
    Address
    12 Hartom Street, Har Hotzvim

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    60.497B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    Harmony Biosciences Holdings, Inc.

    VALUE SCORE:

    12

    Symbol
    HRMY
    Market Cap
    1.551B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Agios Pharmaceuticals, Inc.

    VALUE SCORE:

    12

    Symbol
    AGIO
    Market Cap
    2.373B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.673
    P/S
    0
    P/B
    0.655
    Debt/Equity
    0.064
    EV/FCF
    1.191
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    -1.485
    Debt/assets
    0.045
    FUNDAMENTALS
    Net debt/ebidta
    1.073
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.002
    Capex to revenue
    0
    Capex to depreciation
    0.018
    Return on tangible assets
    -0.676
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.007
    P/CF
    -0.827
    P/FCF
    0
    RoA %
    -67.611
    RoIC %
    -89.651
    Gross Profit Margin %
    0
    Quick Ratio
    2.806
    Current Ratio
    2.806
    Net Profit Margin %
    0
    Net-Net
    8.473
    FUNDAMENTALS PER SHARE
    FCF per share
    -11.673
    Revenue per share
    0
    Net income per share
    -14.300
    Operating cash flow per share
    -11.651
    Free cash flow per share
    -11.673
    Cash per share
    14.849
    Book value per share
    14.710
    Tangible book value per share
    14.710
    Shareholders equity per share
    14.710
    Interest debt per share
    0.945
    TECHNICAL
    52 weeks high
    36.800
    52 weeks low
    8.800
    Current trading session High
    11.097
    Current trading session Low
    9.590
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.

    NEWS
    https://images.financialmodelingprep.com/news/intec-announces-expected-closing-date-of-decoy-merger-20210803.jpg
    Intec Announces Expected Closing Date of Decoy Merger

    prnewswire.com

    2021-08-03 12:45:00

    JERUSALEM, Aug. 3, 2021 /PRNewswire/ -- Intec Parent, Inc. (NASDAQ: NTEC) ("Intec Parent" or the "Company"), today announced that the pending and previously announced reverse merger (the "Decoy Merger") with Decoy Biosystems, Inc. ("Decoy") is currently expected to close after market hours today, Tuesday, August 3, 2021, subject to satisfaction or waiver of all closing conditions. Immediately following the closing, the combined company will be renamed "Indaptus Therapeutics, Inc.", and is expected to begin trading on The Nasdaq Capital Market under the new ticker symbol "INDP" upon the commencement of trading on Wednesday, August 4, 2021.

    https://images.financialmodelingprep.com/news/ntec-stock-10-things-to-know-about-redhot-intec-pharma-20210729.jpg
    NTEC Stock: 10 Things to Know About Red-Hot Intec Pharma

    investorplace.com

    2021-07-29 17:34:27

    NTEC stock is riding high today without any news. It seems investors are getting hyped up ahead of its merger with Decoy Biosystems.

    https://images.financialmodelingprep.com/news/3-biotech-penny-stocks-to-watch-on-robinhood-ipo-20210729.jpg
    3 Biotech Penny Stocks To Watch On Robinhood IPO Day

    pennystocks.com

    2021-07-29 13:11:28

    These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/hot-penny-stocks-to-buy-now-4-you-need-20210722.jpg
    Hot Penny Stocks to Buy Now? 4 You Need to Know About

    pennystocks.com

    2021-07-22 17:06:54

    These hot penny stocks may deserve a place on your watchlist this month The post Hot Penny Stocks to Buy Now? 4 You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/best-penny-stocks-to-buy-before-marijuana-legalization-4-20210713.jpg
    Best Penny Stocks To Buy Before Marijuana Legalization? 4 To Watch Now

    pennystocks.com

    2021-07-13 15:25:29

    Marijuana legalization is a hot topic & some penny stocks are benefiting in 2021. The post Best Penny Stocks To Buy Before Marijuana Legalization?

    https://images.financialmodelingprep.com/news/top-10-biotech-penny-stocks-to-watch-in-july-20210622.jpg
    Top 10 Biotech Penny Stocks to Watch in July 2021

    pennystocks.com

    2021-06-22 16:24:09

    Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/best-penny-stocks-to-buy-now-7-to-watch-20210620.jpg
    Best Penny Stocks To Buy Now? 7 To Watch This Week

    pennystocks.com

    2021-06-20 13:09:25

    What are the best penny stocks to buy this week? The post Best Penny Stocks To Buy Now?

    https://images.financialmodelingprep.com/news/the-week-where-new-york-legalizes-recreational-marijuana-20210401.jpg
    The Week Where New York Legalizes Recreational Marijuana

    schaeffersresearch.com

    2021-04-01 14:33:53

    Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

    https://images.financialmodelingprep.com/news/shareholder-alert-monteverde-associates-pc-announces-an-investigation-of-20210326.jpg
    SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intec Pharma Ltd. - NTEC

    prnewswire.com

    2021-03-26 23:02:00

    NEW YORK, March 26, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Intec Pharma Ltd. ("NTEC" or the "Company") (NTEC) relating to its proposed merger with Decoy Biosystems.

    https://images.financialmodelingprep.com/news/shareholder-alert-weisslaw-llp-investigates-intec-pharma-ltd-20210322.jpg
    SHAREHOLDER ALERT: WeissLaw LLP Investigates Intec Pharma Ltd.

    prnewswire.com

    2021-03-22 20:16:00

    NEW YORK, March 22, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intec Pharma Ltd.  ("Intec" or the "Company") (NASDAQ: NTEC) in connection with the proposed acquisition of the Company by Decoy Biosystems, Inc.("Decoy").

    https://images.financialmodelingprep.com/news/last-weeks-7-biggest-cannabis-moves-20210322.jpeg
    Last Week's 7 Biggest Cannabis Moves

    schaeffersresearch.com

    2021-03-22 12:59:54

    Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

    https://images.financialmodelingprep.com/news/intec-pharma-investor-alert-by-the-former-attorney-general-20210317.jpg
    INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd. - NTEC

    businesswire.com

    2021-03-17 13:47:00

    NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Intec Pharma Ltd. (“the Company”) (NasdaqCM: NTEC) to Decoy Biosystems, Inc. pursuant to which Intec shareholders are expected to only own approximately 25% of the combined company, on a fully diluted basis. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-ntec/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

    https://images.financialmodelingprep.com/news/intec-pharma-announces-filing-of-2020-annual-report-on-20210316.jpg
    Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K

    globenewswire.com

    2021-03-16 20:18:00

    JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. A copy of the annual report is available on Intec's website, www.intecpharma.com, by selecting “Investors” and then “Financials” and “SEC Filings”.

    https://images.financialmodelingprep.com/news/ntec-stock-price-increases-over-80-premarket-why-it-20210315.jpg
    NTEC Stock Price Increases Over 80% Pre-Market: Why It Happened

    pulse2.com

    2021-03-15 08:30:04

    The stock price of Intec Pharma Ltd (NASDAQ: NTEC) increased by over 80% pre-market. This is why it happened.

    https://images.financialmodelingprep.com/news/intec-pharma-and-decoy-biosystems-announce-merger-agreement-20210315.jpg
    Intec Pharma and Decoy Biosystems Announce Merger Agreement

    prnewswire.com

    2021-03-15 08:00:00

    JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with Decoy Biosystems, Inc., a privately-held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime both innate and adaptive anti-tumor and anti-viral immune responses.

    https://images.financialmodelingprep.com/news/intec-pharma-ntec-stock-price-jumped-over-100-why-it-20201209.jpg
    Intec Pharma (NTEC) Stock Price Jumped Over 100%: Why It Happened

    pulse2.com

    2020-12-09 15:14:25

    Shares of Intec Pharma Ltd (NASDAQ:NTEC) surged today as it went from $3.46 per share yesterday to a day high of $7.12 -- which imputes a jump of 105.78%. This is why it happened.